Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03114436
Other study ID # Canada-DONATE 0780-PIA
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 31, 2016
Est. completion date July 31, 2018

Study information

Verified date May 2019
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a 1-year national prospective cohort study that observes the medical management of consented deceased organ donors at hospitals across Canada with a high volume of deceased donation.


Description:

This prospective cohort study enrols consecutive adult deceased organ donors with a waiver of research consent and collects various data related to deceased donor care in the ICU from the time of consent for donation to the time of organ recovery. Clinical data includes donor characteristics, type of donation (after neurological death or cardiocirculatory death), resuscitation methods, cardiopulmonary monitoring techniques, medications, blood work, mechanical ventilation, diagnostic imaging, complications, and methods of death declaration. Various clinical data on deceased donors are collected prospectively from the time of consent for organ donation up to and including the day of organ recovery.

The Canada-DONATE study is designed to develop a national platform for future clinical trials in deceased donor care. The main objectives include:

1. Establish specialized organ donation research teams at participating ICUs.

2. Observe, record, and describe ICU practices in deceased donor care (e.g., donor resuscitation, organ suitability assessments, death declaration) which are likely to vary by site, region and province and will be very important to inform clinical care protocols for future RCTs.

3. Engage and work with ODOs from each province to foster data sharing and develop procedures to enhance efficiency in future RCTs.

4. Investigate the comparative effectiveness of various ICU interventions in deceased donor care to improve the conversion of consented donors to actual donors and to improve the number of transplants per donor.

5. Produce specific knowledge translation tools that will serve in the future as clinical tools to enhance ICU care and research tools to facilitate RCTs.


Recruitment information / eligibility

Status Completed
Enrollment 622
Est. completion date July 31, 2018
Est. primary completion date July 31, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Admitted into a critical care area (ICU, CCU, ER)

- Consent has been obtained for Organ Donation

Exclusion Criteria:

- Admitted into a paediatric critical care area (NICU, PICU)

Study Design


Intervention

Other:
Observational Data Collection
All aspects of deceased donor care in the ICU.

Locations

Country Name City State
Canada Foothills Medical Centre Calgary Alberta
Canada Royal Alexandra Hospital Edmonton Alberta
Canada University of Alberta Hospital Edmonton Alberta
Canada Hamilton Health Science - Juravinski Hospital Hamilton Ontario
Canada Hamilton Health Sciences - Hamilton General Hospital Hamilton Ontario
Canada Kingston General Hospital Kingston Ontario
Canada London Health Sciences Centre - University Hospital London Ontario
Canada London Health Sciences Centre - Victoria Hospital London Ontario
Canada Trillium Health Partners - Trillium Health Centre Mississauga Ontario
Canada Centre hospitalier de l'Université de Montréal - Hôpital Notre-Dame Montreal Quebec
Canada Centre hospitalier de l'Université de Montréal - Hôpital Saint-Luc Montreal Quebec
Canada Centre hospitalier de l'Université de Montréal - Hôtel-Dieu de Montréal Montreal Quebec
Canada Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Général de Montreal Montreal Quebec
Canada Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Royal Victoria Montreal Quebec
Canada Hôpital du Sacré-Cœur de Montréal Montreal Quebec
Canada Hôpital Maisonneuve-Rosemont Montreal Quebec
Canada Royal Columbian Hospital New Westminster British Columbia
Canada The Ottawa Hospital - Civic Campus Ottawa Ontario
Canada The Ottawa Hospital - General Hospital Ottawa Ontario
Canada Centre Hospitalier Universitaire de Québec - Université Laval Quebec
Canada Centre Hospitalier Universitaire de Sherbrooke Sherbrooke Quebec
Canada St Michael's Hospital Toronto Ontario
Canada Sunnybrook Health Sciences Centre Toronto Ontario
Canada University Health Network - Toronto General Hospital Toronto Ontario
Canada University Health Network - Toronto Western Hospital Toronto Ontario
Canada St. Paul's Hospital Vancouver British Columbia
Canada Vancouver General Hospital Vancouver British Columbia
Canada Royal Jubilee Hospital Victoria British Columbia
Canada Victoria General Hospital Victoria British Columbia

Sponsors (10)

Lead Sponsor Collaborator
McMaster University BC Transplant, Canadian Blood Services, Canadian Critical Care Trials Group, Canadian National Transplant Research Program, Hamilton Health Sciences Corporation, Human Organ Procurement and Exchange, Southern Alberta Organ Donation Program, Transplant Quebec, Trillium Gift of Life Network

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to national guidelines for deceased donor care For each donor, we will measure adherence to multiple recommendations from national guidelines for the management of deceased organ donors. Duration of deceased donor care in the ICU (1-5 days per donor).
Secondary Organ donation This refers to the conversion of a consented organ donor to an actual organ donor. Duration of deceased donor care in the ICU (1-5 days per donor).
Secondary Organ transplantation Deceased organ donors can provide up to 8 organ donations each. We will measure the number of transplants that proceed from each consented donor. Transplantation may occur from 1-5 days from the time of consent.
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness